First-Line Therapy Determines Bladder Preservation in High-Grade NMIBC - Peter Black
Peter Black
Peter Black outlines bladder-preservation strategies in high-grade non-muscle invasive bladder cancer to Ashish Kamat, covering first-line optimization through second-line options.
Initial Experience with APC3 "Presentation" - Philipp Backhaus
At the 2026 UCSF-UCLA PSMA Conference, Philipp Backhaus presents first-in-human imaging and compassionate-use treatment data for OncoACP3-DOTA targeting prostatic acid phosphatase.
